Riskpilot← Back to searchSign inGet full accessSAPA Medico AB
ABActiveOrg 5569137804Monsungatan 61 Lägenhet 301General medical practice activities · NACE 8621Est. 20121-4 employees
Revenue 2024
SEK 960K
-2% vs 2023
EBITDA margin
6.1%
-70% vs 2023
Equity ratio
27.4%
Financial strength
Net profit 2024
SEK 45K
-72% vs 2023
| Revenue | SEK 960K | -2% |
| EBITDA | SEK 58K | -70% |
| Net profit | SEK 45K | -72% |
| Total assets | SEK 364K | -23% |
| Equity | SEK 100K | -53% |
| Employees | — | — |
Legal name
SAPA Medico AB
Org number
5569137804
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 december 2012
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Rostamian, Fatemeh
Company purpose
Aktiebolaget ska bedriva läkartjänst, läkartjänstbemanning, läkarmottagning samt därmed förenlig verksamhet.
Address
Monsungatan 61 Lägenhet 301
Email
dr_frostamian@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 452 | 892 | 628 | 981 | 960 |
| Staff expenses | — | — | −147 | −570 | −645 |
| EBITDA | 213 | 453 | 269 | 197 | 58 |
| Depreciation & amort. | −119 | −119 | −119 | — | −3 |
| EBIT | 94 | 334 | 150 | 197 | 55 |
| Net financials | −18 | −8 | −3 | 5 | 3 |
| Profit before tax | 77 | 325 | 148 | 202 | 59 |
| Tax | −21 | −67 | −30 | −42 | −14 |
| Net profit | 56 | 258 | 117 | 161 | 45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 896 | 666 | 320 | 470 | 364 |
| Equity | 183 | 312 | 179 | 215 | 100 |
| Long-term debt | 303 | 119 | 0 | — | — |
| Short-term debt | 410 | 236 | 141 | 256 | 264 |
| Total debt | 713 | 355 | 141 | 256 | 264 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
27.4%
This company
38.2%
Market median
-28% vs market
20202024
Return on equity
45.4%
This company
18.4%
Market median
+147% vs market
20202024
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20202024
Asset turnover
2.64×
This company
1.12×
Market median
+136% vs market
20202024
Debt / equity
2.65×
This company
0.62×
Market median
-327% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SAPA Medico AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Payam Yasrebi | Deputy Board Member | 0 companies |
| Fatemeh Rostamian | Board of Directors | 0 companies |
| Sahand Yasrebi | Deputy Board Member | 0 companies |